Citation Impact
Citing Papers
A microRNA expression signature of human solid tumors defines cancer gene targets
2006 Standout
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017 StandoutNobel
CD44: From adhesion molecules to signalling regulators
2003 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
Cancer to bone: a fatal attraction
2011 Standout
Contribution of platelets to tumour metastasis
2011 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
De novo protein design. I. in search of stability and specificity
1999 StandoutNobel
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin Administration
2008
Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease
1996
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis
1998
STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression
2005
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Recombinant immunotoxins for the treatment of haematological malignancies
2004
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Immunotoxin therapy of cancer
2006
Angiogenesis in health and disease
2003 Standout
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Circos: An information aesthetic for comparative genomics
2009 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Oncomirs — microRNAs with a role in cancer
2006 Standout
Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95
2000
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Epstein–Barr virus: 40 years on
2004 Standout
The incidence of congenital heart disease
2002 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Biology of Hodgkin's lymphoma
2002
Lymphocyte predominant Hodgkin’s disease: Pathology and clinical implication
1998
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
MicroRNA signatures in human cancers
2006 Standout
BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
2005
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Molecular Characterization of a Novel Intracellular Hyaluronan-binding Protein
2000
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
1999
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
1999
Molecular biology of Hodgkin's lymphoma
2002
Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis
2009
Involvement of integrins α3β1 and α5β1 and glycoprotein IIb in megakaryocyte‐induced osteoblast proliferation
2010
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Cancer and the chemokine network
2004 Standout
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Chronic neutrophilic leukemia and multiple myeloma: An association with λ light chain expression
1990
Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation
2001
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
2001 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Immunodeficient Mouse Models of Lymphoid Tumors
2003
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
A strategy for treatment of Epstein–Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells
2003
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Oxygen-Independent Upregulation of Vascular Endothelial Growth Factor and Vascular Barrier Dysfunction during Ventilated Pulmonary Ischemia in Isolated Ferret Lungs
2000 StandoutNobel
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
2000
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
2000
Loss of the B-lineage–specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
2003
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Follicular Helper CD4 T Cells (TFH)
2011 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Cytokines, platelet production and hemostasis
1997
Cytokine Storm
2020 Standout
Mechanisms of Cancer Drug Resistance
2002 Standout
Chimaeric anti‐interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose‐escalating study
1998
Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.
1987
Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow
2010
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
1997
Overview of Castleman disease
2020
Immunotoxins for targeted cancer therapy
1998
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells
2004 Standout
The role of cytokines in classical Hodgkin lymphoma
2002
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Hodgkin's lymphoma
2003
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.
2001
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]
1995 Standout
Interleukin-6 gene expression in Castleman's disease
1991
Autocrine/Paracrine Mechanisms in Human Hematopoiesis
2001
Works of ML Hansmann being referenced
Lymphocyte predominant Hodgkin's disease — a workshop report
1996
Primary lymphomas of the lung: morphological, immunohistochemical and clinical features
1990
Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant
1989
Clonality and germinal centre B-cell derivation of Hodgkin/Reed–Sternberg cells in Hodgkin’s disease
1998
Clinical Trials with an Anti-CD25 Ricin A-Chain Experimental and Immunotoxin (RFT5-SMPT-dgA) in Hodgkin's Lymphoma
1998
Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus.
1992
The blood microvasculature in T-cell lymphomas
1985
First-trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography.
1990
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins
1994
Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells
1996
Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.
1994
Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes
1995
Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins
1994